EDAP edap-tms.com: מקדם חוב לטווח ארוך להון

EDAP TMS S.A. is striving for global dominance in robotic prostate cancer treatment. The long-term debt-to-equity structure on the GURU.Markets chart confirms this trajectory, where the current reading is 1.98. Margin growth driven by consumables mitigates the risks of slow HIFU technology adoption and physician training costs, ensuring the business's financial stability.

This indicator measures the share of long-term borrowings relative to equity, determining financial stability and the cost of servicing long-term leverage. Investors compare this ratio with asset growth rates to assess bankruptcy risks. Analyzing the ratio of long-term liabilities to equity reveals the extent of a company's dependence on external financing. For EDAP TMS S.A. (EDAP), a moderate debt load confirms the stability of its monopoly position. Technological leadership and patent protection allow the issuer to manage capital effectively without excessive credit risks.